NOT-AR-19-032: Notice of NIAMS Participation in PA-18-837: Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Notice of NIAMS Participation in PA-18-837: Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Notice Number: NOT-AR-19-032

Key Dates
Release Date: April 10, 2019

Related Announcements
PA-18-837

Issued by
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

The purpose of this Notice is to inform potential applicants that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will participate, effective immediately, in PA-18-837" Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)."

The following sections of PA-18-837 have been updated to reflect the participation of NIAMS in this Funding Opportunity Announcement (FOA):

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)
National Eye Institute (NEI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of General Medical Sciences (NIGMS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Advancing Translational Sciences (NCATS)
National Heart, Lung, and Blood Institute(NHLBI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.273, 93.866, 93.855, 93.213, 93.394, 93.393, 93.395, 93.396, 93.399, 93.279, 93.121, 93.286, 93.867, 93.859, 93.172, 93.307, 93.361, 93.853, 93.350,93.837, 93.838, 93.839, 93.840, 93.233, 93.846

Part 2 Section I. Funding Opportunity Description

Additional Institute/Center Priorities

NIAMS supports diversity supplements to NIAMS Phase II SBIR/STTR grants at all career levels. At the time of supplement application, the parent grant must have a reasonable period of time remaining (greater than one year) to support an optimal career development experience for the candidate. NIAMS does not award diversity supplements to grants in a no-cost-extension.

Section VII. Agency Contacts

Scientific/Research Contact(s)

Xibin Wang, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: 301-451-3884
Email: [email protected]

Financial/Grants Management Contact(s)

Ms. Leslie Littlejohn
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phone: (301) 594-2545
Email: [email protected]

All other aspects of the FOA remain the same.

You can learn more about the NIAMS' participation in Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR at https://www.niams.nih.gov/grants-funding/diversity-supplement-program/diversity-sbirsttr.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Xibin Wang, Ph.D.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-451-3884
Email: [email protected]

Financial/Grants Management Contact(s)

Ms. Leslie Littlejohn
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Telephone: 301-594-2545
Email: [email protected]